Sucampo Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Sucampo Pharma (SCMP) Tops Q2 EPS by 1c; Reiterates 2017 Guidance
August 2, 2017 6:34 AM EDTSucampo Pharma (NASDAQ: SCMP) reported Q2 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $59.9 million versus the consensus estimate of $56.43 million.
Guidance
Sucampo today reiterated its guidance for the full year ending December 31, 2017. Sucampo... More



